tirzepatide lawsuit 2025 Two lawsuits regarding competition violations hit Novo Nordisk in January Eli Lilly sues companies selling

if it tastes too salty, adjust for next time

GLP-1 receptor agonists should not be used by people with type 1 diabetes, as they are not a substitute for insulin therapy

So, a consumer would be injured by a defective product and could only sue the retailer who wasnt responsible

AOD 9604 does not interact with growth hormone receptors, does not affect insulin signaling, and does not cross into the central nervous system to alter appetite or mood

Weight regain is the most consistent finding after discontinuing tirzepatide, as appetite suppression and metabolic effects fade

The lateral septum is an area of the brain where GLP-1R is highly expressed and is involved in reward-related behaviors, including alcohol-induced reward and alcohol consumption